Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Furoate/Vilanterol in COPD
NCT01053988Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 3 trial of fluticasone, vilanterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Oct 2009; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01053988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053988.